Barba T, Marquet A, Bouvry D, Cohen-Aubart F, Ruivard M, Debarbieux S, et al. Efficacy and safety of infliximab therapy in refractory upper respiratory tract sarcoidosis: experience from the STAT registry. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2018 Feb. 1 [cited 2024 Nov. 26];34(4):343-51. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/5817